| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 4,051,000 | 3,807,000 | 3,638,000 | 5,235,602 | | Cost of Revenue | 2,512,000 | 2,286,000 | 2,270,000 | 3,413,387 | | | Gross Profit | 1,539,000 | 1,521,000 | 1,368,000 | 1,822,215 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,027,000 | 966,000 | 961,000 | 1,101,978 | | Non Recurring | 23,000 | 11,000 | 15,000 | 4,701 | | Others | 150,000 | 144,000 | 141,000 | 142,851 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 339,000 | 400,000 | 251,000 | 572,685 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 21,000 | | Earnings Before Interest And Taxes | 246,000 | 400,000 | 251,000 | 593,685 | | Interest Expense | (62,000) | 30,000 | 32,000 | 50,544 | | Income Before Tax | 308,000 | 370,000 | 219,000 | 543,141 | | Income Tax Expense | 116,000 | 139,000 | 82,000 | 207,268 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 192,000 | 231,000 | 137,000 | 335,873 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 192,000 | 231,000 | 137,000 | 335,873 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $192,000 | $231,000 | $137,000 | $335,873 |
|
0.01% Nasdaq 
Income Statement
